We are live on
!
Find out more
KXA
KPCB XIV Associates Portfolio holdings
AUM
$42.8M
1-Year Est. Return
16.52%
This Fund
S&P 500
This Quarter
Est. Return
-21.35%
1 Year Est. Return
-16.52%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$128M
AUM Growth
-$44M
(-26%)
Cap. Flow
+$1.03M
Cap. Flow
% of AUM
0.8%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
1
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amprius Technologies
AMPX
|
+$1.03M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 58.67% |
| 2 | Consumer Staples | 39% |
| 3 | Healthcare | 1.61% |
| 4 | Industrials | 0.72% |
Similar funds
SIP
AMC
OMC
JMF
MAM
HCM
MCAV
ZAM
KPCB XIV Associates's Q3 2022 Portfolio in Review
As of Q3 2022, KPCB XIV Associates held 6 positions worth $128M, down 26% from $172M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
KPCB XIV Associates's Q3 2022 filing shows 1 new position. Its largest new stake was Amprius Technologies: 100,000 shares worth $922K.
By sector, the portfolio is most concentrated in Consumer Discretionary at 59% of assets, down from 61% a quarter earlier, followed by Consumer Staples and Healthcare.
- KPCB XIV Associates's largest Q3 2022 buy was Amprius Technologies: 100,000 shares worth $922K.
- KPCB XIV Associates's ten largest holdings make up 100% of its $128M portfolio in Q3 2022.
- KPCB XIV Associates opened 1 new position and closed 0 in Q3 2022.
- KPCB XIV Associates's portfolio value fell 26% quarter-over-quarter to $128M.
Based on KPCB XIV Associates's 13F filing for Q3 2022, filed 26 Oct 2022.